All Phenotypes Acvrl1<tm1Enl> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Acvrl1^tm1Enl/Acvrl1^tm1Enl	involves: C57BL/6	MGI:3033419
ht2	Acvrl1^tm1Enl/Acvrl1⁺	B6.Cg-Acvrl1^tm1Enl	MGI:5698247
ht3	Acvrl1^tm1Enl/Acvrl1⁺	involves: C57BL/6	MGI:3033418
ht4	Acvrl1^tm1Spo/Acvrl1^tm1Enl	involves: 129S4/SvJae * C57BL/6	MGI:2680090

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

Abnormal yolk sac and embryo morphology of Acvrl1^tm1Enl/Acvrl1^tm1Enl mice

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:61177 )

• homozygous mutant embryos die at midgestation and are resorbed by E11.5

cardiovascular system

abnormal blood vessel morphology ( J:61177 )

• at E9.5, very few capillary vessels are visible probably because of excessive fusion of capillary plexes (including the intersomitic arteries) into large cavernous vessels

abnormal intersomitic vessel morphology ( J:61177 )

• dilation and fusion of intersomitic vessels

abnormal angiogenesis ( J:61177 )

• vascular lesions are associated with enhanced expression of angiogenic factors and proteases

• homozygous mutant embryos exhibit defective endothelial remodeling; however vasculogenesis is normal

dilated dorsal aorta ( J:61177 )

• at E9.5, mutant embryos exhibit hyperdilation of the dorsal aorta

abnormal vitelline vasculature morphology ( J:61177 )

• at E8.5, the primary capillary plexus in the yolk sac and embryo proper appears normal

• at E9.5, the yolk sac vasculature is highly dilated, and mature blood vessels are absent

• at E10.5, the yolk sac of homozygous mutant embryos is avascular, and blood cells appear clustered

abnormal vascular smooth muscle morphology ( J:61177 )

• mutant embryos display delayed differentiation and mislocalization of vascular smooth muscle cells, resulting in failure to recruit smooth muscle cells around the arteries

arteriovenous malformation ( J:61177 )

• arteriovenous malformations involving arteriovenous shunts are evident by E8.5

dilated vasculature ( J:61177 )

• at E9.5, the lumen of major blood vessels is hyperdilated

dilated pharyngeal arch artery ( J:61177 )

• at E9.5, mutant embryos exhibit hyperdilation of the branchial arch arteries

• branchial arch arteries are greatly dilated and fused with surrounding capillaries, forming large cavernous vessels

abnormal myocardium layer morphology ( J:61177 )

• at E9.5, the mutant myocardium appears to be immature as compared to wild-type

abnormal endocardium morphology ( J:61177 )

• at E9.5, the mutant endocardium appears to be immature as compared to wild-type

enlarged pericardium ( J:61177 )

• at E10.5, mutant embryos exhibit an enlarged pericardium

craniofacial

dilated pharyngeal arch artery ( J:61177 )

• at E9.5, mutant embryos exhibit hyperdilation of the branchial arch arteries

• branchial arch arteries are greatly dilated and fused with surrounding capillaries, forming large cavernous vessels

embryo

dilated pharyngeal arch artery ( J:61177 )

• at E9.5, mutant embryos exhibit hyperdilation of the branchial arch arteries

• branchial arch arteries are greatly dilated and fused with surrounding capillaries, forming large cavernous vessels

abnormal vitelline vasculature morphology ( J:61177 )

• at E8.5, the primary capillary plexus in the yolk sac and embryo proper appears normal

• at E9.5, the yolk sac vasculature is highly dilated, and mature blood vessels are absent

• at E10.5, the yolk sac of homozygous mutant embryos is avascular, and blood cells appear clustered

embryonic growth retardation ( J:61177 )

• at E8.5, mutant embryos appear morphologically normal

• at E9.5, mutant embryos display delayed posterior development

• at E10.5, homozygous mutant embryos become severely distorted and display severe growth retardation

muscle

abnormal vascular smooth muscle morphology ( J:61177 )

• mutant embryos display delayed differentiation and mislocalization of vascular smooth muscle cells, resulting in failure to recruit smooth muscle cells around the arteries

abnormal myocardium layer morphology ( J:61177 )

• at E9.5, the mutant myocardium appears to be immature as compared to wild-type

growth/size/body

embryonic growth retardation ( J:61177 )

• at E8.5, mutant embryos appear morphologically normal

• at E9.5, mutant embryos display delayed posterior development

• at E10.5, homozygous mutant embryos become severely distorted and display severe growth retardation

microcephaly ( J:61177 )

• at E9.5, homozygous mutant embryos become readily identifiable by their smaller head size

Allelic Composition	Acvrl1^tm1Enl/Acvrl1⁺
Genetic Background	B6.Cg-Acvrl1^tm1Enl

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Acvrl1^tm1Enl mutation (0 available); any Acvrl1 mutation (27 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

abnormal circadian regulation of systemic arterial blood pressure ( J:226550 )

• mutants show alterations in arterial pressure circadian rhythm; the reduction in arterial pressure seen during the light period is less pronounced in mutants and they maintain higher arterial pressure during most of the light period

• mutants have higher arterial pressure around midnight compared to wild-type mice

hypertension ( J:226550 )

• mice show increased systolic and diastolic arterial pressure with normal cardiac and renal function

• however, no differences in heart rate, ECG readings, and cardiac function or structure are seen

homeostasis/metabolism

increased circulating adrenaline level ( J:226550 )

• plasma concentrations of epinephrine are higher

decreased circulating angiotensin II level ( J:226550 )

• plasma angiotensin II levels are slightly but significantly lower

increased circulating noradrenaline level ( J:226550 )

• plasma concentrations of norepinephrine are higher

abnormal enzyme/coenzyme activity ( J:226550 )

• renal tissue angiotensin II-converting enzyme activity is lower

abnormal physiological response to xenobiotic ( J:226550 )

• administration of captopril for 4 days decreases systolic arterial pressure to a greater extent than in wild-type mice

• after i.v. angiotensin II administration, the increase in arterial pressure measured by direct cannulation of the carotid artery in anesthetized mice is lower in mutants than in wild-type mice, however the change in vascular resistance in response to angiotensin II is not different

• the contractile response of aortic rings to increasing doses of phenylephrine is lower in mutants than in wild-type mice, even when corrected by KCl-induced contraction

• mutants are more sensitive to the hypotensive effects of intracerebroventricular losartan and less sensitive to the hypertensive effects of intracerebroventricular angiotensin II

nervous system

dilated brain ventricle ( J:226550 )

• some mice show ventricular dilatation

abnormal cholinergic neuron morphology ( J:226550 )

• reduction in the numbers of cholinergic neurons in the anterior basal forebrain

abnormal sympathetic nervous system physiology ( J:226550 )

• hypotensive response to acute administration of a beta-adrenergic receptor antagonist atenolol is greater in mutants than in wild-type mice, however the hypotensive response to acute administration of the alpha-adrenergic receptor antagonist prazosin is similar to wild-type mice, indicating sympathetic nervous system overactivation

renal/urinary system

renal/urinary system phenotype ( J:226550 )

N	• plasma creatinine levels, creatinine clearance, urinary protein excretion, urinary sodium excretion, and kidney morphology appear normal

Allelic Composition	Acvrl1^tm1Enl/Acvrl1⁺
Genetic Background	involves: C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Acvrl1^tm1Enl mutation (0 available); any Acvrl1 mutation (27 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:82115 )

• when allowed to live beyond 1 year of age, some heterozygotes die spontaneously, or are euthanized due to morbidity

cardiovascular system

cardiovascular system phenotype ( J:82115 )

N	• at the age of >1 year, heterozygotes develop an age-dependent hereditary hemorrhagic telangiectasia (HHT)-like phenotype

dilated liver sinusoidal space ( J:82115 )

• sinusoidal capillaries are grossly dilated in affected liver lobes

hemorrhage ( J:82115 )

• the first and most frequently observed external manifestation of vascular pathology is the presence of discolored, cyanotic nailbeds and hemorrhage into claws

• histological examination of affected nailbeds revealed numerous closely packed telangiectases altering the adjacent bone

gastrointestinal hemorrhage ( J:82115 )

• some heterozygous mutants show visible gastrointestinal bleeding, as well as positive fecal occult blood tests

telangiectasia ( J:82115 )

• heterozygotes display vascular lesions (telangiectases) consisting of hyperdilated vessels with normal or thin walls, in isolation or in clusters, in normal or abnormal locations

• vascular lesions are observed in the skin, oral cavity, liver, spleen, lung, intestine and brain

• vascular lesions are often associated with hemorrhage, organ enlargement and/or fibrosis

• at least one vascular lesion is observed in ~40% of heterozygous mutant mice of a predominately C57BL/6 genetic background by the age of 12 months or older

digestive/alimentary system

gastrointestinal hemorrhage ( J:82115 )

• some heterozygous mutants show visible gastrointestinal bleeding, as well as positive fecal occult blood tests

liver/biliary system

abnormal hepatobiliary system morphology ( J:82115 )

• the range of gross liver lesions include focal lesions that are ~1-2 mm in diameter and consist of multiple thin-walled vessels that are hyperdilated and juxtaposed to each other

• liver lesions are the most predominant among vascular defects, and are associated with chronic hemorrhage, fibrosis, and morbidity

• one heterozygous mutant mouse with severe liver pathology, including hepatic arteriovenous malformations, also displayed a secondary cardiac phenotype, comprising of myocardial ischemia and loss

dilated liver sinusoidal space ( J:82115 )

• sinusoidal capillaries are grossly dilated in affected liver lobes

enlarged liver ( J:82115 )

muscle

telangiectasia ( J:82115 )

• heterozygotes display vascular lesions (telangiectases) consisting of hyperdilated vessels with normal or thin walls, in isolation or in clusters, in normal or abnormal locations

• vascular lesions are observed in the skin, oral cavity, liver, spleen, lung, intestine and brain

• vascular lesions are often associated with hemorrhage, organ enlargement and/or fibrosis

• at least one vascular lesion is observed in ~40% of heterozygous mutant mice of a predominately C57BL/6 genetic background by the age of 12 months or older

growth/size/body

enlarged liver ( J:82115 )

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
hereditary hemorrhagic telangiectasia		DOID:1270	OMIM:187300 OMIM:600376 OMIM:601101 OMIM:615506	J:82115

Allelic Composition	Acvrl1^tm1Spo/Acvrl1^tm1Enl
Genetic Background	involves: 129S4/SvJae * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Acvrl1^tm1Enl mutation (0 available); any Acvrl1 mutation (27 available)
Acvrl1^tm1Spo mutation (0 available); any Acvrl1 mutation (27 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

embryonic lethality during organogenesis, complete penetrance ( J:85877 )

• heterozygotes die around E9.5-E10.5

cardiovascular system

abnormal vascular development ( J:85877 )

• severe vascular defects at E9.5-E10.5 when heterozygotes die

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 10/29/2024 MGI 6.24